Wikidata

(Q62822383)

English

A Safety Study of Retinal Gene Therapy for Choroideremia

clinical trial

In more languages

Statements

short name
GEMINI (English)
0 references
title
An Open-Label Safety Study of Retinal Gene Therapy for Choroideremia With Bilateral, Sequential Administration of Adeno-Associated Viral Vector (AAV2) Encoding Rab Escort Protein 1 (REP1) (English)
0 references
start time
6 November 2017
0 references
end time
31 March 2020
0 references
number of participants
15
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q62822383&oldid=1857085573"